Literature DB >> 16896359

Understanding psychological aspects of chronic pain in interventional pain management.

Laxmaiah Manchikanti1, Bert Fellows, Vijay Singh.   

Abstract

There is no doubt that chronic pain is recognized as a biopsychosocial phenomenon in which biological, psychological, and social factors dynamically interact with each other. Thus, the role of psychological factors and understanding chronic, persistent disabling pain has been well recognized, but poorly understood. Approximately 1/2 to 2/3 of all patients diagnosed with chronic pain manifest to various levels of psychological distress. Chronic pain and psychological disorders are the two most common elements in the United States. Statistics show that, approximately 22% of Americans suffer from a diagnosable mental disorder in a given year. In addition, 28% of the American population suffers with chronic pain. Depression in chronic pain is the most common condition, followed by generalized anxiety disorder, somatization disorder, and drug dependence. However, psychogenic pain appears to be the least prevalent of all psychopathological issues. Chronic pain disability is a complex psychosocial economic phenomenon. There is no data in the literature with regards to treatment of personality disorders, anxiety disorders, and somatization disorders in managing chronic pain. In contrast, treatment of depression and the influence of treatment on outcomes have been studied to some extent. In conclusion, patients with chronic pain frequently have psychopathology - most often common depressive disorders, anxiety disorders, somatization disorders, drug dependence and occasionally personality disorders. This review discusses various issues involved with psychopathology in chronic pain including epidemiology; relationship of psychopathology to pain; influence of depression, generalized anxiety disorder, somatization, and personality disorders on chronic pain, along with diagnosis and management in interventional pain management.

Entities:  

Year:  2002        PMID: 16896359

Source DB:  PubMed          Journal:  Pain Physician        ISSN: 1533-3159            Impact factor:   4.965


  12 in total

1.  The development and psychometric validation of the central sensitization inventory.

Authors:  Tom G Mayer; Randy Neblett; Howard Cohen; Krista J Howard; Yun H Choi; Mark J Williams; Yoheli Perez; Robert J Gatchel
Journal:  Pain Pract       Date:  2011-09-27       Impact factor: 3.183

Review 2.  Alexithymia in Chronic Pain Disorders.

Authors:  Marialaura Di Tella; Lorys Castelli
Journal:  Curr Rheumatol Rep       Date:  2016-07       Impact factor: 4.592

Review 3.  Psychological Interventions for the Management of Chronic Pain: a Review of Current Evidence.

Authors:  Ronald S Kaiser; Mira Mooreville; Kamini Kannan
Journal:  Curr Pain Headache Rep       Date:  2015-09

4.  Increased c-fos expression in the central nucleus of the amygdala and enhancement of cued fear memory in Dyt1 DeltaGAG knock-in mice.

Authors:  Fumiaki Yokoi; Mai T Dang; Courtney A Miller; Andrea G Marshall; Susan L Campbell; J David Sweatt; Yuqing Li
Journal:  Neurosci Res       Date:  2009-07-18       Impact factor: 3.304

5.  The Effects of Pre-treatment Depressive Symptoms on Quality of Life Across Cognitive Behavioral Therapy for Chronic Pain.

Authors:  Justin M Hughes; Eric A Seemann; J Michael George; K Dean Willis
Journal:  J Clin Psychol Med Settings       Date:  2019-03

6.  Preclinical screening of phyllanthus amarus ethanolic extract for its analgesic and antimicrobial activity.

Authors:  S Sham Bhat; K Sundeep Hegde; Sharath Chandrashekhar; S N Rao; Shyamjith Manikkoth
Journal:  Pharmacognosy Res       Date:  2014 Oct-Dec

7.  Psychological predictors of change in the number of musculoskeletal pain sites among Norwegian employees: a prospective study.

Authors:  Jan Olav Christensen; Sissel Johansen; Stein Knardahl
Journal:  BMC Musculoskelet Disord       Date:  2017-04-04       Impact factor: 2.362

8.  Alexithymia is associated with greater risk of chronic pain and negative affect and with lower life satisfaction in a general population: the Hisayama Study.

Authors:  Mao Shibata; Toshiharu Ninomiya; Mark P Jensen; Kozo Anno; Koji Yonemoto; Seiko Makino; Rie Iwaki; Koji Yamashiro; Toshiyuki Yoshida; Yuko Imada; Chiharu Kubo; Yutaka Kiyohara; Nobuyuki Sudo; Masako Hosoi
Journal:  PLoS One       Date:  2014-03-12       Impact factor: 3.240

Review 9.  Comorbidity Factors and Brain Mechanisms Linking Chronic Stress and Systemic Illness.

Authors:  Vanja Duric; Sarah Clayton; Mai Lan Leong; Li-Lian Yuan
Journal:  Neural Plast       Date:  2016-02-08       Impact factor: 3.599

10.  Satisfaction, Adherence and Health-Related Quality of Life with Transdermal Buprenorphine Compared with Oral Opioid Medications in the Usual Care of Osteoarthritis Pain.

Authors:  Philip G Conaghan; Michael Serpell; Paula McSkimming; Rod Junor; Sara Dickerson
Journal:  Patient       Date:  2016-08       Impact factor: 3.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.